Capturing MultiORgan Effects of COVID-19
Launched by UNIVERSITY OF OXFORD · Aug 11, 2020
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The C-MORE study is a research project aimed at understanding how COVID-19 can affect different organs in people who have survived the illness after being discharged from the hospital. Researchers want to find out how common these organ issues are and how they impact survivors' quality of life, ability to exercise, and mental health. The study is currently looking for participants aged 18 and older who have had a confirmed moderate to severe case of COVID-19 and have been hospitalized for at least 48 hours. There are also opportunities for healthy participants who have never had COVID-19 to join the study as a comparison group.
If you decide to participate, you will go through some assessments, including an MRI scan, to help researchers learn more about the effects of COVID-19 on your body. It's important to note that certain conditions, like pregnancy or having a pacemaker, may prevent someone from taking part in the study. The goal is to gather valuable information that could help improve care for future COVID-19 patients and understand the long-term effects of the virus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the study.
- • Male or Female, aged 18 years or above.
- • Diagnosis of COVID-19 infection confirmed by detection of viral nucleic acid on reverse-transcription Polymerase Chain Reaction (RT-PCR).
- • Infection should be of moderate to severe intensity (i.e, patients with clinical signs of pneumonia such as respiratory rate \> 30 breaths/min; or severe respiratory distress; or SpO2 \< 90% (on room air) and admission for \>48 hours.
- • Controls: Participants with no serological evidence of previous infection, or active/previous symptoms suggestive of COVID-19, and who may or may not have comorbidities.
- Exclusion Criteria:
- • Contraindication to MRI e.g. pregnancy, pacemaker, ferromagnetic implant, shrapnel injury, severe claustrophobia, inability to lie flat.
- • Any other significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study.
- • Any signs of active COVID-19 infection on day of visit.
- • Significantly impaired renal function (eGFR\<30 ml/min)
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials